MK-0518
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK-0518, covering 2015-09-17 to 2019-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression [Phase 3]